Fig. 7
From: Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways
Phenformin treatment combined with gefitinib impaired cellular migration in wound healing assays. a–c Photographs showing gaps in the scratched regions of MB49, T24, and UMUC3 monolayers subsequently treated with the indicated drug alone or combination. Control wells received no drug. d–f Wound closure distances measured from the experiments shown in panels (a–c). Results are mean ± SD of three independent experiments. *P < 0.05, #P < 0.01 vs. control